Clinical Trial Update: A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME) [Phase 2]

View source ↗

Summary

Pfizer-sponsored Phase 2 clinical trial investigating a novel drug for diabetic macular edema has been withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• Not disclosed

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Diabetic Retinopathy | Phase 2 | Status: WITHDRAWN